Newly released survey results offer insights into current product lifecycle supply chain challenges experienced by innovator and generics pharmaceutical organisations, disruptions caused by the COVID-19 pandemic, personnel staffing strains, future market directions, and more.
Pharmaceutical executives shared views on:
- The most difficult product lifecycle supply chain stages
- Greatest challenges at the development, the manufacturing/packaging, sell stage, and sourcing stages
- Leading pandemic-related industry supply chain impacts
- Most implemented solutions to address supply chain challenges
- Current dosage form trends
The results of this survey are an interesting window into both long-existing industry challenges, issues worsened by the volatility of the pandemic, and the evolutions of a changing market.